Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
9.05
0.00
(0.00%)
At close: 5:00:01 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-21,356.67
-11,859.32
-10,213.38
-13,496.42
57,435.48
Investing Cash Flow
-38,788.10
-44,506.72
-33,585.51
-18,823.38
8,579.41
Financing Cash Flow
3,748.28
54,736.39
7,377.36
13,856.79
20,448.37
End Cash Position
28,582.60
63,988.14
65,617.79
102,039.32
120,502.32
Capital Expenditure
-38,840.38
-44,521.76
-33,631.35
-18,834.56
-2,086.17
Issuance of Capital Stock
--
49,099.80
117.02
4,838.68
--
Free Cash Flow
-60,197.05
-56,381.07
-43,844.73
-32,330.98
55,349.31
12/31/2020 - 4/19/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
96X.F FluoGuide A/S
3.7650
+0.27%
RGO.DU Regeneron Pharmaceuticals Inc
658.20
+0.12%
PH4.F CStone Pharmaceuticals
0.3720
0.00%
MAGLE.ST Magle Chemoswed Holding AB (publ)
32.60
-3.55%
600161.SS TIANTAN BIO
19.93
-0.60%
HQ1.MU Oruka Therapeutics Inc. R
10.60
0.00%
BSSP Baseline Productions, Inc.
0.0001
0.00%
GYX.F Futura Medical plc
0.1330
-24.86%
BXPHF Botanix Pharmaceuticals Limited
0.2650
-8.62%
10VA.F Immunic, Inc.
1.1250
-8.98%